FDA green-lights Cordis vascular stent for SFA, PPA

The FDA has approved Cordis' S.M.A.R.T. Control vascular stent systems for use in the superficial femoral artery (SFA) and/or the proximal popliteal artery (PPA).

The S.M.A.R.T. stent, which has been approved for peripheral indication in international markets since 1999, is now the first stent in the U.S. with both iliac and SFA indications. The clinical data supporting the FDA approval of the S.M.A.R.T. stent for use in the peripheral vasculature was obtained through the STROLL investigational device exemption (IDE) trial that enrolled 250 patients at 39 clinical sites within the U.S.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup